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respiratory gating for breast cancer patients. Respiratory 
gating and proton therapy are two important approaches 
aimed at improving dose conformity to the target volume and 
decreasing the radiation burden to the normal tissues. 
Respiratory gating could increase the volume of the lungs or 
the anatomical separation between the heart and the high 
dose region. Proton therapy could reduce the 
cardiopulmonary burden and increase dose conformity to the 
target due to the finite range of the particles and the virtual 
zero dose deposition beyond their Bragg peak. 
Materials and Methods: Twenty left-sided patients (10 
treated to the breast and the supraclavicular lymph nodes - 
BSC - and 10 treated to whole breast only - WBO) were 
included in the analysis. The patients were planned in the 
end inspiration phase of enhanced inspiration breathing, first 
with 3DCRT photon therapy and then with single field 
uniform dose (SFUD) and intensity modulated proton therapy 
(IMPT) with scanned pencil beams. Photon and proton plans 
were optimised so that beam angles used were to provide 
adequate coverage of the PTV and also limit the dose spilling 
to the contralateral side. The prescribed dose was 50 Gy(RBE) 
in 25 fractions, assuming an RBE of 1.1 for the protons. 
Dosimetric parameters characterising the coverage of the 
clinical target volume of tumour (CTV-T) and the planned 
target volume (PTV), as well as the cardiopulmonary burden 
were determined and compared using a paired, two-tailed 
Student’s t-test. 
Results: The protons ensured comparable or better target 
coverage than photons in all patients. The heterogeneity 
index decreased from 12.0% with photons to 5.2% with IMPT 
(p<0.0001). Also, the volume of the 105% dose hotspot in the 
PTV decreased from 3.5% with photons to 0.1% with protons. 
The coverage of the PTV with the 93% isodose was also 
improved from 98.3% with photons to 99.7% with IMPT 
(p<0.0001). There was also tendency towards decreasing the 
normal tissue radiation burden with protons, except for the 
volume of the ipsilateral lung receiving doses above 10 Gy 
that was higher for protons than for photons in WBO patients, 
but not for BSC treatments (Figure 1). Dividing the patients in 
subgroups depending on the potential of gating to reduce 
heart and LAD doses with photons, a different trend was 
however observed where the WBO group with the highest 
benefit from gating appears to have higher maximum doses 
to the LAD with protons, but the correlation was not 
statistically significant (p=0.3). 
 
 
 
Conclusions: Spot scanning with protons appears to further 
reduce the doses to the OARs even for patients that do not 
benefit from photon therapy using respiratory gating. This 
indicates a potential for protons for the treatment of breast 
cancer especially for patients with unfavourable anatomy and 
comorbidity characteristics.  
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Purpose/Objective: Newer but more complex radiation 
techniques allow very precise irradiation with better dose 
homogeneity and coverage of the target volumes with more 
sparing of the organs at risk (OAR). However, to take full 
advantage of these radiation techniques, the delineation of 
the target volumes and OAR should be correct. Therefore, a 
national project with a central review and correction of the 
delineations of the regional nodal areas (RNA) using the new 
national delineation guidelines was started. We investigated 
whether the introduction of new delineation guidelines has 
an impact on daily treatment planning. 
Materials and Methods: Six months after the start of the 
national central review study for the delineations of the RNA 
in breast radiotherapy, all participating centers were 
provided with an electronic questionnaire, containing 5 
simple questions about the impact of the new delineation 
guidelines on the treatment planning. 
Results: Sixteen out of 19 centers (84%) have completed the 
questionnaire. Half of these centers have changed 
dosimetrical parameters such as the use of higher energies 
and/or have changed their planning technique. Thirty-one 
percent of the centers have changed their treatment 
planning by introducing a new technique such as SIB (6%), 
IMRT (6%), field-in-field radiotherapy (6%), conformal-3D 
radiotherapy (6%) or the oblique parasternal photon 
technique (6%). Most of the centers (82%) base the treatment 
planning on the centrally reviewed and corrected target 
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volume delineation. Reasons for non-compliance are mostly 
problems with target coverage. Thirty-eight percent of the 
centers reported issues with target coverage; in 1 center 
they interpret the Dose Volume Histogram differently and are 
now looking at the 85% coverage of the planning target 
volume instead of the 95%. 
Conclusions: The introduction of new delineation guidelines 
for the RNA in breast radiotherapy has a major impact on the 
treatment planning and dosimetry with especially introducing 
newer treatment techniques to achieve better target 
coverage. Surprisingly, not all centers use the centrally 
reviewed and corrected target delineation to guide their 
radiotherapy to the RNA.  
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Purpose/Objective: In the era of fast technological evolution 
in breast radiotherapy (RT), a correct delineation of the 
target volumes becomes more and more important. The 
objective in this study is to investigate the performance of 
the accuracy of the delineation of the regional nodal areas 
(RNA) by different radiation-oncologists and to determine the 
most difficult regions to contour. 
Materials and Methods: Before the start of the national 
central review study for the delineation of the RNA in breast 
RT, all participating centers were asked to delineate all the 
different RNA on a CT-scan with intravenous contrast of one 
specific patient. The delineation guidelines as well as the 
delineation atlases, covering both target volumes and normal 
anatomy, were provided. The obtained contours were 
compared with the reference contour to evaluate the 
conformity using the overlapping volume (OV). The OV is 
defined by the intersection of the obtained contour with the 
reference contour divided by the union of those contours.  
Results: Twenty-two radiation-oncologists of 15 different 
radiotherapy departments performed the delineation of the 
RNA of that one specific case. In general, the mean OV of all 
lymph node regions together was 0.52 (± std 0.12). The most 
problematic areas were the rotter space and the internal 
mammary lymph node region (figure), with a mean OV of 
respectively 0.42 (± std 0.09) and 0.48 (± std 0.09). Level IV 
(= supraclavicular) and level I of the axilla were contoured 
the best with a mean OV of 0.6 (± std 0.13) and 0.56 (± std 
0.08), followed by level III and level II of the axilla with a 
mean OV of respectively 0.53 (± std 0.11) and 0.51 (± std 
0.11). 
Conclusions: Delineation of the regional nodal areas in breast 
radiotherapy is not easy with a large intercenter and 
interobserver variation, even in the presence of extensively 
written guidelines and clear atlases. The most difficult areas 
to contour in this pilot study were the rotter space and the 
internal mammary node region. The national central review 
study will tell us if practicing and central review lead to 
better contouring. 
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Purpose/Objective: Upper abdominal SBRT is significantly 
compromised by late toxicity to bowel structures, mostly 
stomach, duodenum and small bowel and to a lesser degree 
also colon. Often ablative doses cannot be prescribed without 
infringement of dose constraints to bowel organs at risk 
(OAR), limiting SBRT to selected places had distant from 
bowel structures. 
Materials and Methods: We developed a method of SBRT 
where all doses were prescribed according to ICRU 
guidelines. After generation of the main planning target 
volume (PTV) by isotropic expansion of 4 mm from internal 
target volume (ITV) as determined by 4D-imaging. We then 
defined a high dose SIB-PTV by a negative margin of 10 mm of 
the ITV. Dose prescribed to the SIB-PTV was 122-125% of the 
dose prescribed to the main PTV. Additionally, we defined a 
SIP-PTV by subtracting the planning risk volume (PRV) of a 
bowel OAR created by a 4 mm margin expansion of the OAR 
structure. Dose prescribed to the SIP-PTV was chosen to meet 
the defined dose constraints to OARs as described by 
Timmerman in 2008. Two fractionation regimes were used, 5 
or 12 fractions, given every other day. Five fraction regimens 
